Edition:
United Kingdom

Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

33.60PLN
17 Sep 2018
Change (% chg)

-0.40zł (-1.18%)
Prev Close
34.00zł
Open
34.45zł
Day's High
34.45zł
Day's Low
33.60zł
Volume
4,137
Avg. Vol
13,500
52-wk High
37.00zł
52-wk Low
27.88zł

Summary

Name Age Since Current Position

Maciej Wieczorek

Chairman of the Management Board, Chief Executive Officer

Iwona Giedronowicz

Member of the Management Board, Chief Financial Officer

Bogdan Manowski

Member of the Management Board, Director for Business Development

Krzysztof Kaczmarczyk

41 2018 Independent Member of the Supervisory Board

Michal Kowalczewski

Independent Member of the Supervisory Board

Robert Rzeminski

Member of the Supervisory Board

Artur Wieczorek

Member of the Supervisory Board

Urszula Wieczorek

Member of the Supervisory Board

Malgorzata Siewierska

Investor Relations Contact Officer

Biographies

Name Description

Maciej Wieczorek

Dr. Maciej Wieczorek serves as Chairman of the Management Board and Chief Executive Officer of Celon Pharma S.A. He has served as Chairman of the Management Board of Novazil Therapeutics, Celon Services and held the same position at Mabion S.A. until 2016. He holds a Doctorate of Medicine degree in Medical Biology from Uniwersytet Medyczny w Lodzi (2009), as well as a degree in Industrial Management from Politechnika Warszawska. Dr. Wieczorek has completed MBA studies program at Szkola Glowna Handlowa in Warsaw in cooperation with University of Minnesota.

Iwona Giedronowicz

Ms. Iwona Maria Giedronowicz is Member of the Management Board and Chief Financial Officer of Celon Pharma S.A. She graduated from the Faculty of Economics, Finance and Accounting of Uniwersytet Warszawski. From 1997 to 2001 she was Head of the Accounting Department at Finanspol. Moreover, she was responsible for Finance and Accounting at Tebodin Poland Sp. z o.o., Celon Pharma Sp. z o.o. and Celon Services Sp. z o.o.

Bogdan Manowski

Mr. Bogdan Szczepan Manowski is Member of the Management Board and Director for Business Development of Celon Pharma S.A. He graduated from Szkola Glowna Handlowa w Warszawie and obtained an MBA degree from Uniwersytet Warszawski. From 1997 to 2001 he served at Eli Lilly Polska Sp. z o.o. and later at GSK Commercial Sp. z o.o.

Krzysztof Kaczmarczyk

Mr. Krzysztof Robert Kaczmarczyk has served as Independent Member of the Supervisory Board of Celon Pharma S.A. since April 9, 2018. In 2011 he graduated from Szkola Glowna Handlowa w Warszawie. He started his career at Deutsche Morgan Greenfell, where in 2002 he served as Analyst Assistant. From 2002 to 2007 he was an Analyst at DB Securities S.A. and from 2008 to 2010 he worked for Grupa TP S.A. From 2010 to 2011 he served at Credit Suisse in Poland. From 2012 to 2015 he was Vice Chairman of the Management Board for Strategy and Development at Emitel. He has been on the Supervisory Board of Action, Arteria, Alta, Braster, BSC Drukarnia Opakowan, Gielda Papierow Wartosciowych, LC Corp, KGHM, Work Service, TIM, Best, Integer, SARE, Magellan, Robyg, InPost, Polimex-Mostostal, Duon, Polish Energy Partners, Graal, Wirtualna Polska, 4fun Media.

Michal Kowalczewski

Dr. Michal Krzysztof Kowalczewski is Independent Member of the Supervisory Board of Celon Pharma S.A. He is Member of the Audit Committee at the Company. He holds a doctorate degree in Economics and graduated from Szkola Glowna Handlowa w Warszawie. He is Chairman of the Management Board of Mercurius Financial Advisors Sp. z o.o. and Mercurius Dom Maklerski Sp. z o.o.

Robert Rzeminski

Mr. Robert Stanislaw Rzeminski serves as Member of the Supervisory Board of Celon Pharma S.A. He is Member of the Audit Committee at the Company. He holds Masters degree in Chemistry from Uniwersytet Wroclawski. For many years he has served as JELFA S.A. From 2005 to 2007 he was Chairman of the Management Board of OINPHARMA Sp. z o.o. and from 2007 to 2013 he served as Vice Chairman of the Management Board of Bioventures Partners Sp. z o.o.

Artur Wieczorek

Mr. Artur Wieczorek serves as Member of the Supervisory Board of Celon Pharma S.A. He joined the Company in 2013 as Technical Analyst. From 2014 to 2015 he was Chairman of the Management Board of Novazil Therapeutics Sp. z o.o.

Urszula Wieczorek

Ms. Urszula Wieczorek serves as Member of the Supervisory Board of Celon Pharma S.A. She has many years of experience in real estate. Since 2005, she has been associated with Celon Pharma S.A.

Malgorzata Siewierska

Basic Compensation